1-4 of 4
Leigh MacConell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Multiple Doses of Exenatide Once-Monthly Suspension in Patients With Type 2 Diabetes: A Phase II Randomized Clinical Trial

Free
Carol H. Wysham, Leigh MacConell, Elise Hardy
Journal: Diabetes Care
Diabetes Care 2016;39(10):1768–1776
https://doi.org/10.2337/dc16-0238
Published: 19 July 2016
View articletitled, Efficacy and Safety of Multiple Doses of Exenatide Once-Monthly Suspension in Patients With Type 2 Diabetes: A Phase II Randomized Clinical Trial
Open the PDF for Efficacy and Safety of Multiple Doses of Exenatide Once-Monthly Suspension in Patients With Type 2 Diabetes: A Phase II Randomized Clinical Trial in another window
Includes: Supplementary data
Journal Articles

Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes

Open Access
Michaela Diamant, Michael A. Nauck, Rimma Shaginian, James K. Malone, Simon Cleall, Matthew Reaney, Danielle de Vries, Byron J. Hoogwerf, Leigh MacConell, Bruce H.R. Wolffenbuttel, for the 4B Study Group
Journal: Diabetes Care
Diabetes Care 2014;37(10):2763–2773
https://doi.org/10.2337/dc14-0876
Published: 10 September 2014
View articletitled, Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes
Open the PDF for Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks

Open Access
Michaela Diamant, MD, Luc Van Gaal, MD, Stephen Stranks, MD, Bruno Guerci, MD, Leigh MacConell, PHD, Harry Haber, MPH, Jamie Scism-Bacon, PHD, Michael Trautmann, MD
Journal: Diabetes Care
Diabetes Care 2012;35(4):683–689
https://doi.org/10.2337/dc11-1233
Published: 13 March 2012
View articletitled, Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks
Open the PDF for Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks in another window
Includes: Supplementary data
Journal Articles

Effects of Once-Weekly Dosing of a Long-Acting Release Formulation of Exenatide on Glucose Control and Body Weight in Subjects With Type 2 Diabetes

Free
Dennis Kim, MD, Leigh MacConell, PHD, Dongliang Zhuang, PHD, Prajakti A. Kothare, PHD, Michael Trautmann, MD, Mark Fineman, MS, Kristin Taylor, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(6):1487–1493
https://doi.org/10.2337/dc06-2375
Published: 01 June 2007
View articletitled, Effects of Once-Weekly Dosing of a Long-Acting Release Formulation of Exenatide on Glucose Control and Body Weight in Subjects With Type 2 Diabetes
Open the PDF for Effects of Once-Weekly Dosing of a Long-Acting Release Formulation of Exenatide on Glucose Control and Body Weight in Subjects With Type 2 Diabetes in another window